NCT00203359|CompletedPhase 1
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease
Etanercept for Alzheimer's-Type Memory Loss Pilot Study
Loading search results
Etanercept for Alzheimer's-Type Memory Loss Pilot Study
Sponsor study identifier
interventional
15
1 country
1
Study Start
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
It is widely believed that inflammation contributes to the pathogenesis of AD. TNF has been implicated in both AD and neurological inflammation. Anti-TNF therapy is therefore surmised to be of potential benefit for treating AD.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
September 12, 2005
Actual (reported)September 20, 2005
Actual (reported)April 2006
Date type not reportedThis date has not been verified as actual or estimated.
ADAS-Cog
SIB
MMSE
Category fluency
other neuropsychological tests
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Edward Tobinick, MD (private medical office)
Los Angeles, California, 90095, United States
Edward L Tobinick, MD
unaffiliated (Assistant Clinical Professor of Medicine, David Geffen School of Medicine at UCLA)
First Submitted
September 12, 2005
First Posted
September 20, 2005
Study Start
September 2004
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
April 2006
Date type not reportedAnti-Oxidant Treatment of Alzheimer's Disease
Contact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
April 24, 2006
Record last verified: 2006-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: